<p>Contraception and pregnancy prevention for transgender and gender nonbinary individuals across the gender spectrum </p><p>Chance Krempasky, FNP, WHNP (he/him) Callen-Lorde Community Health Center <br>New York, NY USA </p><p><strong>Intros/Who's in the room? </strong></p><p><strong>A Little About Callen-Lorde... </strong><br><strong>Introduction </strong></p><p>• Transmasculine persons (TMGNB=transgender men and gender nonbinary persons who are assigned female at birth), may utilize testosterone as part of gender affirmingtherapy </p><p>• They may have a uterus + ovaries and be capable of achieving pregnancy <br>• They also may engage in sexual activity which can achieve pregnancy </p><p><strong>TMGNB people can still get pregnant, even if they are on testosterone and </strong></p><p><strong>haven’t had a recent period. </strong></p><p><strong>Pregnancy in TMGNB persons </strong></p><p>• 31% trans masculine persons, 67% trans femininepersons believed or were unsure if gender affirminghormone therapy (GAHT) prevents pregnancy </p><p>• 6% trans feminine, 9% trans masculine reported that a provider stated that GAHT prevents pregnancy </p><p>• 3% TMGNB/trans masculine had </p><p>unplanned pregnancies </p><p><strong>Contraception Knowledge in TMGNB </strong></p><p><strong>Persons </strong></p><p>• Many believed testosteronefunctioned as a contraceptive </p><p>• Respondents reported receiving unclear or confusing informationfrom clinicians on need for </p><p>contraception while on GAHT </p><p>• Concerned contraception would interfere with </p><p>masculinizing effectsof GAHT </p><p><strong>Pregnancy in TMGNB Persons </strong></p><p>• 16.4% of TMGNB persons believed that GAHT is a contraceptive • 5.5% reported a provider stated that GAHT prevents pregnancy • 17% had been or were currently pregnant (11/60 pregnancies with current or past GAHT use) </p><p>• 60 pregnancies reported, 10 (17%) pregnancies occurred after stopping testosterone, 1 (1.6%) while taking testosterone irregularly </p><p><strong>Clinical Barriers to TransmasculineContraception </strong></p><p>• Unger, AJOG 2015: <br>• Less than one third of OBGYN clinicians surveyed recently stated that they were comfortable providing care forTM individuals </p><p>• NCTE U.S. Transgender Survey, 2015: <br>• One third of transgender respondents who had engaged in healthcare reporting at least one negative experience related to their gender identity, including verbal harassment and being </p><p>refused care </p><p>• Krempasky, AJOG 2019 <br>• TM patients may want to avoid estrogen and/or progesterone due to perceived feminizing effectsof these hormones and association with an incongruent gender </p><p>Will Betke-Brunswick, </p><p>"A Trans Man’s Experience With Birth </p><p>Control" </p><p><strong>and estrogen! </strong></p><p>• Pregnancy can occur even while amenorrheic from testosterone </p><p><strong>Effects of GAHT on Fertility </strong></p><p>• GAHT's long term effects on fertility are unclear </p><p>• True decrease in fecundityafter discontinuance </p><p>of testosterone has yet to be ascertained <br>• All patients considering starting GAHT should be counseled about options for fertilitypreservation<sup style="top: -0.5em;">1 </sup></p><p>• Use of GAHT does not guarantee infertility <br>• The time to return of fertilityis unknown, route </p><p>dependent (topical vs short/long-acting </p><p>injectable testosterone), though some may experience permanent loss of fertility,or require assisted reproductive technologies </p><p>1. WPATH SOC7 </p><p><strong>Effects of Gender Affirming Hormone Therapy on Fertility </strong></p><p>• It is unknown how long of a testosterone washout period is appropriate prior to pregnancy </p><p>• Testosterone is a teratogen and is contraindicated during pregnancy </p><p>• GAHT is not a substitute for contraception in patients wishing to prevent pregnancy </p><p><strong>Why Isn't Testosteronea Contraception? </strong></p><p>Changes in both LH and FSH occur in hyperandrogenic systems (both in amplitudeand pulsatility), <br>Androgen Receptors </p><p>however they are not suppressed to prepubertal levels<sup style="top: -0.4375em;">1-3 </sup></p><p>1. Haraldsen et al, <em>Horm Behav</em>. 2007 </p><p>2. Spinder et al <em>J Clin Endocrinol Metab</em>. 1989 </p><p>3. Van Caenegem et al <em>Curr Opin Endocrinol Diabetes Obes</em>. 2015 </p><p><strong>Language and Gender </strong></p><p>Language about fertilityis very gendered </p><p>“women’s health,” “well woman visits,” “GYN,” etc </p><p>**Use gender-neutral terms whenever possible </p><p><strong>Naming Anatomy </strong></p><p>Patients may use different words to describe their body </p><p>parts from “anatomical” terms </p><p>Mirror language that people use for their own body parts </p><p><strong>Alternatives to Current Gendered Terminology </strong></p><p>Krempasky, et al. 2019 </p><p><strong>Suggested Sexual History Script </strong></p><p>Krempasky, et al. 2019 </p><p><strong>Anatomic Inventory </strong></p><p><strong>Organs Present Surgical Hx </strong></p><p>❑ Breasts ❑ Cervix </p><p>❑ Ovaries ❑ Penis ❑ Prostate </p><p>❑ Testes ❑ Uterus ❑ Vagina <br>❑ Bilateral breast augmentation ❑ Bilateral orchiectomy </p><p>❑ Vaginoplasty (penile inversion, colon graft) ❑ Bilateral total reduction mammoplasty ❑ Vaginectomy </p><p>❑ Metoidioplasty ❑ Phalloplasty ❑ Scrotoplasty ❑ Urethroplasty </p><p><strong>Who Needs Contraception? </strong></p><p>Krempasky, et al. 2019 </p><p><strong>Case Study #1 </strong></p><p>Danny, a 27yo G0P0 trans man comes in to ask questions about his pregnancy risk. He has been on testosterone for 1 year. He is monogamous with a trans female partner who is on estradiol injections and spironolactone, and who has had no bottom surgeries. He has condomless receptive frontal and anal sex with her. He wants </p><p>to know if it’s possible for him to get pregnant. </p><p>PMH: Anxiety, PSH: None, Meds: escitalopram 10mg po daily, testosterone cypionate 80mg subcutaneously weekly </p><p><strong>Case Study #1 </strong></p><p>How would you counsel this patient? </p><p>Will Betke-Brunswick, </p><p>"A Trans Man’s </p><p>Experience With Birth Control" <br>Will Betke-Brunswick, </p><p>"A Trans Man’s Experience With Birth Control" </p><p><strong>Contraception for Transgender Men </strong></p><p>1. No methods are contraindicated specifically due to TMGNB identity or hormone use </p><p>2. Comparative efficacyis the same as in use by cisgender women (LARCs > others) </p><p>3. Various aspects (insertion, side effects) of </p><p>contraceptive methods may uniquely affect </p><p>TMGNB patients </p><p>Contraception for Transgender Men </p><p>Krempasky, et al. 2019 </p>
Details
-
File Typepdf
-
Upload Time-
-
Content LanguagesEnglish
-
Upload UserAnonymous/Not logged-in
-
File Pages45 Page
-
File Size-